These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21176309)

  • 1. Postpartum hemorrhage in a Jehovah's Witness patient controlled with Tisseel, tranexamic acid, and recombinant factor VIIa.
    Arab TS; Al-Wazzan AB; Maslow K
    J Obstet Gynaecol Can; 2010 Oct; 32(10):984-7. PubMed ID: 21176309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy-associated breast cancer: a review for the obstetrical care provider.
    Somerset D
    J Obstet Gynaecol Can; 2011 Sep; 33(9):897-898. PubMed ID: 21923985
    [No Abstract]   [Full Text] [Related]  

  • 3. [Obstetric Surgery with High Risk of Postpartum Hemorrhage in a Jehovah's Witness].
    Carp M; Maurício S; Lança F
    Acta Med Port; 2021 Mar; 34(4):300-303. PubMed ID: 34214421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIIa for major obstetric haemorrhage in a Jehovah's Witness.
    Laird R; Carabine U
    Int J Obstet Anesth; 2008 Apr; 17(2):193-4. PubMed ID: 18308545
    [No Abstract]   [Full Text] [Related]  

  • 5. Preferences of Jehovah's Witnesses regarding haematological supports in an obstetric setting: experience of a single university teaching hospital.
    Husarova V; Donnelly G; Doolan A; Garstka M; Ni Ainle F; McCaul C
    Int J Obstet Anesth; 2016 Feb; 25():53-7. PubMed ID: 26597403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemostatic resuscitation in postpartum hemorrhage - a supplement to surgery.
    Ekelund K; Hanke G; Stensballe J; Wikkelsøe A; Albrechtsen CK; Afshari A
    Acta Obstet Gynecol Scand; 2015 Jul; 94(7):680-692. PubMed ID: 25660118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven).
    Tanaka KA; Waly AA; Cooper WA; Levy JH
    Anesthesiology; 2003 Jun; 98(6):1513-5. PubMed ID: 12766668
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of Labour and Delivery in a Patient With Acquired Factor VII Deficiency With Inhibitor: A Case Report.
    Matei A; Dolan S; Andrews J; Rivard GÉ
    J Obstet Gynaecol Can; 2016 Feb; 38(2):160-3. PubMed ID: 27032741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of intestinal hemorrhage in a Jehovah's Witness patient.
    Veneri D; Franchini M
    Am J Hematol; 2005 Aug; 79(4):344-5. PubMed ID: 16044447
    [No Abstract]   [Full Text] [Related]  

  • 10. Major obstetric hemorrhage.
    Le Gouez A; Mercier FJ
    Transfus Clin Biol; 2016 Nov; 23(4):229-232. PubMed ID: 27592155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of anaemia in the polytrauma Jehovah's Witness.
    Murphy DP; O'Donnell T; McDonnell J; McElwain JP
    Ir Med J; 2003 Jan; 96(1):8-10. PubMed ID: 12617434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa?
    Ballen J; Raabe M; Muirhead B
    Can J Anaesth; 2006 Apr; 53(4):353-6. PubMed ID: 16575032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage.
    Mercier FJ; Bonnet MP
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):310-6. PubMed ID: 20216063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta.
    Mechsner S; Baessler K; Brunne B; Albrecht T; Hopp H; Dudenhausen JW
    Fertil Steril; 2008 Nov; 90(5):2012.e1-5. PubMed ID: 18462726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing postburn injury anemia in a Jehovah's Witness patient.
    Barsun A; Sen S; Palmieri TL; Greenhalgh DG
    J Burn Care Res; 2014; 35(4):e258-61. PubMed ID: 24121804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa.
    Mindikoglu AL; Anantharaju A; George M; Leone N; Bejna J; Van Thiel DH
    Hepatogastroenterology; 2003; 50(53):1697-9. PubMed ID: 14571820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant factor viia in a jehovah's witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage.
    Waddington DP; McAuley FT; Hanley JP; Summerfield GP
    Br J Haematol; 2002 Oct; 119(1):286-8. PubMed ID: 12358947
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of pregnancy in a Jehovah's Witness.
    Gyamfi C; Berkowitz RL
    Obstet Gynecol Clin North Am; 2007 Sep; 34(3):357-65, ix. PubMed ID: 17921004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia.
    Virchis A; Hughes C; Berney S
    Hematol J; 2004; 5(3):281-2. PubMed ID: 15167918
    [No Abstract]   [Full Text] [Related]  

  • 20. CASE 12-2016 Ascending Aorta Dissection in a Jehovah's Witness Patient on Warfarin.
    Silvetti S; Crivellari M; Castiglioni A; Landoni G; Zangrillo A; Alfieri O; Koster A; Faraoni D; Bolliger D; Tanaka KA
    J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1709-1715. PubMed ID: 27639716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.